Company CVAbout Alembic Ltd 
Alembic Ltd
Small Cap
Pharmaceuticals & Drugs
Alembic Limited is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in three lines of business, manufacture of Bulk Drugs, Real Estate and Power Generation through Windmills and Co-gen Power Plant which is presently used for captive consumption for the operation of the Bulk Drugs Manufacturing plant at Vadodara.
Company Coordinates
Company Details
Alembic Road , Vadodara Gujarat : 390003
Registrar Details
Link Intime India Pvt Ltd., B-102 & B103, Shangrila Complex, First Floor, Opp: HDFC Bank, Near Radhakrishna Char Rasta, Akota, Vadodara
Capital StructureCapital Structure
Present Equity Capital
INR 53.41 Cr
Number of Shares
26.7 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
27-Sep-2013
26.7
53.41
133515914
2
Bonus
27-Sep-2013
26.7
53.41
133515914
2
Bonus
11-Nov-2009
13.38
26.75
-9510
2
Buy Back of Shares
11-Nov-2009
13.35
26.70
-244866
2
Buy Back of Shares
11-Nov-2009
13.38
26.75
-9510
2
Buy Back of Shares
11-Nov-2009
13.35
26.70
-244866
2
Buy Back of Shares
10-Nov-2009
13.38
26.76
-3864
2
Buy Back of Shares
10-Nov-2009
13.38
26.75
-12636
2
Buy Back of Shares
10-Nov-2009
13.38
26.76
-3864
2
Buy Back of Shares
10-Nov-2009
13.38
26.75
-12636
2
Buy Back of Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 53 FIIs (1.78%)
Promoter with highest holding
Nirayu Limited (63.06%)
Highest Public shareholder
None
Individual Investors Holdings
21.76%
Board of Directors
Management
Designation
Remuneration
Chirayu R Amin
Chairman (Non-Executive)
1.7 lacs
Malika C Amin
Managing Director & CEO
1.44 cr
C P Buch
Independent Director
3.8 lacs
Udit Amin
Director
2.0 lacs
Abhijit Joshi
Director
1.8 lacs
Sameer Khera
Independent Director
3.2 lacs
Drigesh Mittal
Company Sec. & Compli. Officer
0
Rati Desai
Independent Director
1.7 lacs
Mayank Amin
Independent Director
3.2 lacs
Girish Hirode
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Materials Consumed
6.9185
0%
Cost of Materials Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Excise Duty Recovered on Sales
1.78
1.42%
Excise Duty Recovered on Sales
Excise Duty Recovered on Sales
Stock DNARevenue and Profits:
Net Sales:
58 Cr
(Quarterly Results - Dec 2024)
Net Profit:
65 Cr
Pharmaceuticals & Drugs
INR 2,506 Cr (Small Cap)
8.00
33
2.59%
-0.01
13.82%
1.10
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
